Grunenthal Logo

External Link

You are now leaving the Grünenthal website. You will be re-directed to an external website. Grünenthal accepts no responsibility for the content of other websites.

Title
Description
Trial IDHP8001-01
CompoundAdorlan®
Trials sponsorGrünenthal Colombiana S.A.
Trial phase
Brief titlePharmacokinetic Non-interaction Study With a Fixed-dose Combination Tablet With Tramadol and Diclofenac
Indication
UTN
CTG IDNCT03766984
CTIS ID (former EudraCT)
Trial statusCompleted
FPIJune 7, 2015
LPOJune 23, 2015
CountriesFrance, Germany, Spain, United Kingdom
Gender
Age18 and 80 years
ResultsYes
Pubmed
Documents
HP8001-01 | Grünenthal